- Email: [email protected]
Contributors to volume 283
Contributors to V o l u m e 2 8 3 Article numbers are in parentheses following the names of contributors. Affiliations listed are current.
HERMANN BUJARD (12), Zentrum far Molekulare Biologie, 69120 Heidelberg, Germany
PETER D . A D A M S ( 5 ) , Dana-Farber Cancer Institute, Boston, Massachusetts 02115 NATALIE G. AnN (3), Howard Hughes Medical Institute, Department of Chemistry and Biochemistry, University of Colorado, Boulder, Colorado 80309 SOREN S. L. ANDERSEN (2), EMBL, Cell Biology Programme, D 69117 Heidelberg, Germany CHANG BAI (11), Verna and Marrs McLean Department of Biochemistry, Howard Hughes Medical Institute, Baylor College of Medicine, Houston, Texas 77030 MOHAN K. BALASUBRAMANIAN(37), Howard Hughes Medical Institute and Department of Cell Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232 UDO BARON (]2), Zentrum fiir Molekulare Biologie, 69120 Heidelberg, Germany DOUGLAS E. BASSETr, JR. (10), Department of Molecular Biology and Genetics, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205-2185, and The National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, Maryland 20894 J. JULIAN BLOW (41), Imperial Cancer Research Fund, Clare Hall Laboratories, South Mimms, Hefts. EN6 3LD, England MARK BOGUSKI (10), The National Centerfor Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, Maryland 20894 ANGELIKA L. BON1N (12), BASF Bioresearch Corporation, Worcester, Massachusetts 01605-4314 LINDA L. BREEDEN (25), Fred Hutchinson Cancer Research Center, Division of Basic Sciences, Seattle, Washington 98109
JUDITH L. CAMPBELL (30), Braun Laboratories, California Institute of Technology, Pasadena, California 91125 ANTONY M. CARR (36), MRC Cell Mutation Unit, Sussex University, Brighton BN1 9RR, United Kingdom REY-HuEI CHEN (43), Department of Physiology, University of California, San Francisco, San Francisco, California 94143-0444 YONG CH1 (28), California Institute of Technology, Pasadena, California 91125 JAMES P. J. CHONG (41), Imperial Cancer Research Fund, Clare Hall Laboratories, South Mimms, Hefts. EN6 3LD, England DAWN COVERLEY (40), Wellcome/CRC Institute, Cambridge CB2 1QR, United Kingdom VINCENT L. CRYNS (7), Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115 JAMES DEGREGORI (15), Department of Genetics, Howard Hughes Medical Institute, Duke University Medical Center, Durham, North Carolina 27710 RAYMOND J. DESHAIES (28), California Institute of Technology, Pasadena, California 91125 JOHN F. X. DIFFLEY (29), Imperial Cancer Research Fund, Clare Hall Laboratories, South Mimms, Hefts. EN6 3LD, United Kingdom WENDY J. DIXON (30), Braun Laboratories, California Institute of Technology, Pasadena, California 91125 WILLIAM G. DUNPHY (42), Division of Biology, Howard Hughes Medical Institute, California Institute of Technology, Pasadena, California 91125 ix
X
CONTRIBUTORS TO VOLUME 283
B. D. DYNLACHT(17), Department of Molecular and Cellular Biology, Harvard Medical School, Cambridge, Massachusetts 02138 RHIAN J. EDWARDS(36), MRC Cell Mutation Unit, Sussex University, Brighton BN1 9RR, United Kingdom S. J. ELLEDGE (11, 17, 31), Verna and Marts McLean Department of Biochemistry, Department of Molecular and Human Genetics, Baylor College of Medicine, Howard Hughes Medical Institute, Houston, Texas 77030 PETER A. FANTES (34), Institute of Cell and Molecular Biology, University of Edinburgh, Edinburgh EH9 3JT, United Kingdom ANNE FERNANDEZ (6), Cell Biology Unit, Centre de Recherche de Biochimie Macro° moleculaire, Centre National de la Recherche Scientifique, 34033 Montpellier Cedex, France RUSSELL R. PINCHER (39), The Weis Center for Research, Geisinger Clinic, Danville, Pennsylvania 17822 ROBERTP. FISHER(19), Program in Cell Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021 ELLA FREULICH(18), Department of Biological Sciences, Columbia University, New York, New York 10027 SABINE FREUNDLIEB (12), Zentrum far Molekulare Biologie, 69120 Heidelberg, Germany ANDREWM. FRY (20), Department of Molecular Biology, University of Geneva, 1211 Geneva 4, Switzerland MARTIN FUNK (23), MediGene AG, D-82152 Martinsried/Munich, Germany DAVID M. GLOVER (47), Cancer Research Campaign, Cell Cycle Genetics Group, Department of Anatomy and Physiology, MedicaISciences Institute, Universityof Dundee, Dundee DD1 4HN, Scotland MANFREDGOSSEN(12), Division of Biochemistry and Molecular Biology, Department of Molecular and Cell Biology, University of California, Berkeley, California 94720
KATHLEEN L. GOULD (37), Howard Hughes Medical Institute and Department of Cell Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232 WOLFF GRAULICH(23), Institut far Molekularbiologie und Tumorforschung (IMT), Philipps- Universititt Marburg, D-35033 Marburg, Germany STEVENI . HAASE(24), Department of Molecular Biology, The Scripps Research Institute, La Jolla, California 92037 E. HARLOW(17), Massachusetts GeneralHospital Cancer Center, Charlestown, Massachusetts 021292 J. W. HARPER (16, 17), Department of Biochemistry, Baylor College of Medicine, Houston, Texas 77030 AVRAM HERSHKO(46), Unit of Biochemistry, Rappaport Faculty of Medicine and Rappaport Institute for Research in Medical Sciences, Technion-IsraelInstitute of Technology, Haifa 31096, Israel PHILIPHIETER (10), Department of Molecular Biology and Genetics, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205-2185 M1NGXIA HUANG (31), Verna and Marts McLean Department of Biochemistry, Department of Molecular and Human Genetics, Baylor College of Medicine, Howard Hughes Medical Institute, Houston, Texas 77030 LASZLOJAKOI (15), Howard Hughes Medical Institute, Department of Genetics, Duke University Medical Center, Durham, North Carolina 27710 LATA JAYARAMAN(18), Department of Biological Sciences, Columbia University, New York, New York 10027 ANTHONYL. JOHNSON(26), Division of Yeast Genetics, National Institute for Medical Research, London NW7 1AA, United Kingdom LELAND H. JOHNSTON(26), Division of Yeast Genetics, National Institute for Medical Research, London NW7 1AA, United Kingdom
CONTRIBUTORS TO VOLUME 283 WILLIAM G. KAELIN, JR. (5), Dana-Farber Cancer Institute, Boston, Massachusetts 02115 ERIC KARSENTI (2), EMB L, CellBiology Programme, D 69117 Heidelberg, Germany BRUCE E. KEMP (31), St. Vincent's Institute of Medical Research, Victoria 3065, Australia SUNG-Hou KIM (9), Melvin Calvin Laboratory, University of California, Berkeley, Berkeley, California 94720 RANDALL W. KING (7), Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115 MARC W. KIRSCHNER (7), Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115 SALLY KORNBLUTH (45), Department of Molecular Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710 AKIKO KUMAGAI (42), Division of Biology, California Institute of Technology, Pasadena, California 91125 NED J. C. LAMB (6), Cell Biology Unit, Centre de Recherche de Biochimie Macromoleculaire, Centre National de la Recherche Scientifique, 34033 Montpellier Cedex, France XIAOHONG LENG (10, Department of Biochemistry, Baylor College of Medicine, Houston, Texas 77030 GUSTAVO LEONE (15), Howard Hughes Medical Institute, Department of Genetics, Duke University Medical Center, Durham, North Carolina 27710 DANIEL J. LEW (24), Department of Molecular Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710 PETER LOPEZ (5), Cytomation, Inc., Fort Collins, Colorado 80525 KEVIN D. LUSTIG (7), Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115 DAVID LYDALL (32), Department of Molecular and Cellular Biology, University of Arizona, Tucson, Arizona 85721
xi
STUART A. MACNEILL (34), Institute of Cell and Molecular Biology, University of Edinburgh, Edinburgh EH9 3JR, United Kingdom MARK A. MADINE (40), Wellcome/CRC Institute, Cambridge CB2 1QR, United Kingdom HIRO M. H. MAHBUBANI (41), Imperial Cancer Research Fund, Clare Hall Laboratories, South Mimms, Herts. EN6 3LD, England DANNELL McCOLLUM (37), Howard Hughes Medical Institute and Department of Cell Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232 THOMAS J. MCGARRY (7), Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115 PAUL E. MEAD (7), Howard Hughes Medical Institute and Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115 LAURENT MEIJER (9), Centre National de la Recherche Scientifique, Station Biologique de Roscoff, 29682 Roscoff Cedex, France SEROIO MORENO (4), Instituto de Microbiologia Bioquimica, CSIC/Universidad de Salamanca, Edificio Departmental, Campus Miguel de Unamuno, 37007 Salamanca,
Spain ROLE MOLLER (23), Institut far Molekularbiologie und Tumorforschung (1MT), Philipps- Universiti~t Marburg, D-35033 Marburg, Germany DOMINIK MUMBERG (23), Department of Pathology, The University of Chicago, Chicago, Illinois 60637 MONICA S. MURAKAMI (44), ABL-Basic Research Program, NCI-Frederick Cancer Research and Development Center, Frederick, Maryland 21702 ANDREW W. MURRAY (33, 42), Department of Physiology, University of California at San Francisco, San Francisco, California 94143-0444 KENTARO NABESHIMA (35), Department of Biophysics, Faculty of Science, Kyoto University, Kyoto 606-01, Japan
xii
CONTRIBUTORS TO VOLUME 283
JOSEPHR. NEVINS(15), Howard Hughes Medical Institute, Department of Genetics, Duke University Medical Center, Durham, North Carolina 27710 C. NGWU (17), Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts 021292 ERICH A. NIGG (20), Department of Molecular Biology, Universityof Geneva, 1211 Geneva 4, Switzerland TAKEHARU NISHIMOTO (22), Department of Molecular Biology, Graduate School of Medical Science, Kyushu University, Fukuoka 812-82, Japan CHRIS NORBURY (4), Molecular Oncology Laboratory, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom STEPHEN A. OSMANI (39), The Weis Center for Research, Geisinger Clinic, Danville, Pennsylvania 17822 MATH-IIASPETER (27), Swiss Institute for Experimental Cancer Research, (ISREC), 1066 Epalinges, Switzerland DAWN E. PHELPS (14), Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-3280 JONATHONPINES (8), WeUcome/CRCInstitute and Department of Zoology, Cambridge CB2 1QR, United Kingdom RANDY Y. C. POON (21), Department of BiDchemistry, Hong Kong University of Science and Technology, ClearwaterBay, Kowloon, Hong Kong CAROLPRIVES(18), Department of Biological Sciences, Columbia University, New York, New York 10027 KATHERYN A. RESING (3), Department of Chemistry and Biochemistry, University of Colorado, Boulder, Colorado 80309 VOLKER R(bNICKE (23), Max-Planck-lnstitut fiir klinische und physiologische Forschung, Kerckhoff-Institut, D-61231 Bad Nauheim, Germany ALISON ROWELS (41), Imperial Cancer Research Fund, Clare Hall Laboratories, South Mimms, Herts. EN6 3LD, England
JOANV. RUDERMAN(46), Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115 PAULRUSSELL(38), Department of Molecular Biology, The Scripps Research Institute, La Jolla, California 92037 ALICIAA. RUSSO(1), Memorial Sloan-Kettering Cancer Center, Cellular Biochemistry and Biophysics Program, New York, New York 10021 SHIGEAKI SAITOH (35), Department of Biophysics, Faculty of Science, Kyoto University, Kyoto 606-01, Japan YOLANDA SANCHEZ (31), Verna and Marts McLean Department of Biochemistry, Baylot College of Medicine, Houston, Texas 77030 CORRADOSANTOCANALE(29), Imperial Cancer Research Fund, Clare Hall Laboratories, South Mimms, Hens. EN6 3LD, United Kingdom WILLIAM R. SELLERS(5), Dana-Farber Cancer Institute, Boston, Massachusetts 02115 ROBERTJ. SHEAFF(13), Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104 KAZUHIRO SHIOZAKI (38), Department of Molecular Biology, The Scripps Research Institute, La JoUa, California 92037 LILIA STEPANOVA(16), Department of Biochemistry, Baylor College of Medicine, Houston, Texas 77030 AARON F. STRAIGHT (33), Department of Physiology, University of California at San Francisco, San Francisco, California 94143-0444 P. TODDSTUKENBERG(7), Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115 VALERY SUDAKIN(46), Unit of Biochemistry, Rappaport Faculty of Medicine and Rappaport Institute for Research in Medical Sciences, Technion-IsraelInstitute of Technology, Haifa 31096, Israel E. C. SWINDELL (17), Verna and Marts McLean Department of Biochemistry, Baylot College of Medicine, Houston, Texas 77030
CONTRIBUTORS TO VOLUME 283
xiii
/~kLVARO TAVARES (47), Cancer Research
YUE XIONG (14), Department of Biochemistry
Campaign, Cell Cycle Genetics Group, Department of Anatomy and Physiology, Medical Sciences Institute, University of Dundee, Dundee DD1 4HN, Scotland PIA THt3MMES (41), Imperial Cancer Research Fund, Clare Hall Laboratories, South Mimms, Hefts. EN6 3LD, England NICOLE VALTZ (27), Programs in Genetics and Cell Biology, Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, California 94143-0448 GEORGE F. VANDE WOUDE (44), ABL-Basic Research Program, NCI-Frederick Cancer Research and Development Center, Frederick, Maryland 21702 RATI VERMA (28), California Institute of Technology, Pasadena, California 91125 TED WEINERT (33), Department of Molecular and Cellular Biology, University of Arizona, Tucson, Arizona 85721 HEIKE WILHELM (2), EMBL, Cell Biology Programme, D 69117Heidelberg, Germany J. WINSTON (17), Department of Biochemistry, Baylor College of Medicine, Houston, Texas 77030
and Biophysics, Program in Molecular Biology and Biotechnology, Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-3280 GANG XU (39), Department of Pathology and
Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 MITSUH1RO YANAGIDA (35), Department of
Biophysics, Faculty of Science, Kyoto University, Kyoto 606-01, Japan XIAN~ S. YE (39), The Weis Center for Re-
search, Geisinger Clinic, Danville, Pennsylvania 17822 JUNYING YUAN (7), Department of Cell Biol-
ogy, Harvard Medical School, Boston, Massachusetts 02115 ZHENG ZHOC (31), Department of Biology,
Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 LEONARD I. ZON (7), Howard Hughes Medi-
cal Institute and Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115
HERMANN BUJARD (12), Zentrum far Molekulare Biologie, 69120 Heidelberg, Germany
PETER D . A D A M S ( 5 ) , Dana-Farber Cancer Institute, Boston, Massachusetts 02115 NATALIE G. AnN (3), Howard Hughes Medical Institute, Department of Chemistry and Biochemistry, University of Colorado, Boulder, Colorado 80309 SOREN S. L. ANDERSEN (2), EMBL, Cell Biology Programme, D 69117 Heidelberg, Germany CHANG BAI (11), Verna and Marrs McLean Department of Biochemistry, Howard Hughes Medical Institute, Baylor College of Medicine, Houston, Texas 77030 MOHAN K. BALASUBRAMANIAN(37), Howard Hughes Medical Institute and Department of Cell Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232 UDO BARON (]2), Zentrum fiir Molekulare Biologie, 69120 Heidelberg, Germany DOUGLAS E. BASSETr, JR. (10), Department of Molecular Biology and Genetics, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205-2185, and The National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, Maryland 20894 J. JULIAN BLOW (41), Imperial Cancer Research Fund, Clare Hall Laboratories, South Mimms, Hefts. EN6 3LD, England MARK BOGUSKI (10), The National Centerfor Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, Maryland 20894 ANGELIKA L. BON1N (12), BASF Bioresearch Corporation, Worcester, Massachusetts 01605-4314 LINDA L. BREEDEN (25), Fred Hutchinson Cancer Research Center, Division of Basic Sciences, Seattle, Washington 98109
JUDITH L. CAMPBELL (30), Braun Laboratories, California Institute of Technology, Pasadena, California 91125 ANTONY M. CARR (36), MRC Cell Mutation Unit, Sussex University, Brighton BN1 9RR, United Kingdom REY-HuEI CHEN (43), Department of Physiology, University of California, San Francisco, San Francisco, California 94143-0444 YONG CH1 (28), California Institute of Technology, Pasadena, California 91125 JAMES P. J. CHONG (41), Imperial Cancer Research Fund, Clare Hall Laboratories, South Mimms, Hefts. EN6 3LD, England DAWN COVERLEY (40), Wellcome/CRC Institute, Cambridge CB2 1QR, United Kingdom VINCENT L. CRYNS (7), Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115 JAMES DEGREGORI (15), Department of Genetics, Howard Hughes Medical Institute, Duke University Medical Center, Durham, North Carolina 27710 RAYMOND J. DESHAIES (28), California Institute of Technology, Pasadena, California 91125 JOHN F. X. DIFFLEY (29), Imperial Cancer Research Fund, Clare Hall Laboratories, South Mimms, Hefts. EN6 3LD, United Kingdom WENDY J. DIXON (30), Braun Laboratories, California Institute of Technology, Pasadena, California 91125 WILLIAM G. DUNPHY (42), Division of Biology, Howard Hughes Medical Institute, California Institute of Technology, Pasadena, California 91125 ix
X
CONTRIBUTORS TO VOLUME 283
B. D. DYNLACHT(17), Department of Molecular and Cellular Biology, Harvard Medical School, Cambridge, Massachusetts 02138 RHIAN J. EDWARDS(36), MRC Cell Mutation Unit, Sussex University, Brighton BN1 9RR, United Kingdom S. J. ELLEDGE (11, 17, 31), Verna and Marts McLean Department of Biochemistry, Department of Molecular and Human Genetics, Baylor College of Medicine, Howard Hughes Medical Institute, Houston, Texas 77030 PETER A. FANTES (34), Institute of Cell and Molecular Biology, University of Edinburgh, Edinburgh EH9 3JT, United Kingdom ANNE FERNANDEZ (6), Cell Biology Unit, Centre de Recherche de Biochimie Macro° moleculaire, Centre National de la Recherche Scientifique, 34033 Montpellier Cedex, France RUSSELL R. PINCHER (39), The Weis Center for Research, Geisinger Clinic, Danville, Pennsylvania 17822 ROBERTP. FISHER(19), Program in Cell Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021 ELLA FREULICH(18), Department of Biological Sciences, Columbia University, New York, New York 10027 SABINE FREUNDLIEB (12), Zentrum far Molekulare Biologie, 69120 Heidelberg, Germany ANDREWM. FRY (20), Department of Molecular Biology, University of Geneva, 1211 Geneva 4, Switzerland MARTIN FUNK (23), MediGene AG, D-82152 Martinsried/Munich, Germany DAVID M. GLOVER (47), Cancer Research Campaign, Cell Cycle Genetics Group, Department of Anatomy and Physiology, MedicaISciences Institute, Universityof Dundee, Dundee DD1 4HN, Scotland MANFREDGOSSEN(12), Division of Biochemistry and Molecular Biology, Department of Molecular and Cell Biology, University of California, Berkeley, California 94720
KATHLEEN L. GOULD (37), Howard Hughes Medical Institute and Department of Cell Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232 WOLFF GRAULICH(23), Institut far Molekularbiologie und Tumorforschung (IMT), Philipps- Universititt Marburg, D-35033 Marburg, Germany STEVENI . HAASE(24), Department of Molecular Biology, The Scripps Research Institute, La Jolla, California 92037 E. HARLOW(17), Massachusetts GeneralHospital Cancer Center, Charlestown, Massachusetts 021292 J. W. HARPER (16, 17), Department of Biochemistry, Baylor College of Medicine, Houston, Texas 77030 AVRAM HERSHKO(46), Unit of Biochemistry, Rappaport Faculty of Medicine and Rappaport Institute for Research in Medical Sciences, Technion-IsraelInstitute of Technology, Haifa 31096, Israel PHILIPHIETER (10), Department of Molecular Biology and Genetics, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205-2185 M1NGXIA HUANG (31), Verna and Marts McLean Department of Biochemistry, Department of Molecular and Human Genetics, Baylor College of Medicine, Howard Hughes Medical Institute, Houston, Texas 77030 LASZLOJAKOI (15), Howard Hughes Medical Institute, Department of Genetics, Duke University Medical Center, Durham, North Carolina 27710 LATA JAYARAMAN(18), Department of Biological Sciences, Columbia University, New York, New York 10027 ANTHONYL. JOHNSON(26), Division of Yeast Genetics, National Institute for Medical Research, London NW7 1AA, United Kingdom LELAND H. JOHNSTON(26), Division of Yeast Genetics, National Institute for Medical Research, London NW7 1AA, United Kingdom
CONTRIBUTORS TO VOLUME 283 WILLIAM G. KAELIN, JR. (5), Dana-Farber Cancer Institute, Boston, Massachusetts 02115 ERIC KARSENTI (2), EMB L, CellBiology Programme, D 69117 Heidelberg, Germany BRUCE E. KEMP (31), St. Vincent's Institute of Medical Research, Victoria 3065, Australia SUNG-Hou KIM (9), Melvin Calvin Laboratory, University of California, Berkeley, Berkeley, California 94720 RANDALL W. KING (7), Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115 MARC W. KIRSCHNER (7), Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115 SALLY KORNBLUTH (45), Department of Molecular Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710 AKIKO KUMAGAI (42), Division of Biology, California Institute of Technology, Pasadena, California 91125 NED J. C. LAMB (6), Cell Biology Unit, Centre de Recherche de Biochimie Macromoleculaire, Centre National de la Recherche Scientifique, 34033 Montpellier Cedex, France XIAOHONG LENG (10, Department of Biochemistry, Baylor College of Medicine, Houston, Texas 77030 GUSTAVO LEONE (15), Howard Hughes Medical Institute, Department of Genetics, Duke University Medical Center, Durham, North Carolina 27710 DANIEL J. LEW (24), Department of Molecular Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710 PETER LOPEZ (5), Cytomation, Inc., Fort Collins, Colorado 80525 KEVIN D. LUSTIG (7), Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115 DAVID LYDALL (32), Department of Molecular and Cellular Biology, University of Arizona, Tucson, Arizona 85721
xi
STUART A. MACNEILL (34), Institute of Cell and Molecular Biology, University of Edinburgh, Edinburgh EH9 3JR, United Kingdom MARK A. MADINE (40), Wellcome/CRC Institute, Cambridge CB2 1QR, United Kingdom HIRO M. H. MAHBUBANI (41), Imperial Cancer Research Fund, Clare Hall Laboratories, South Mimms, Herts. EN6 3LD, England DANNELL McCOLLUM (37), Howard Hughes Medical Institute and Department of Cell Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232 THOMAS J. MCGARRY (7), Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115 PAUL E. MEAD (7), Howard Hughes Medical Institute and Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115 LAURENT MEIJER (9), Centre National de la Recherche Scientifique, Station Biologique de Roscoff, 29682 Roscoff Cedex, France SEROIO MORENO (4), Instituto de Microbiologia Bioquimica, CSIC/Universidad de Salamanca, Edificio Departmental, Campus Miguel de Unamuno, 37007 Salamanca,
Spain ROLE MOLLER (23), Institut far Molekularbiologie und Tumorforschung (1MT), Philipps- Universiti~t Marburg, D-35033 Marburg, Germany DOMINIK MUMBERG (23), Department of Pathology, The University of Chicago, Chicago, Illinois 60637 MONICA S. MURAKAMI (44), ABL-Basic Research Program, NCI-Frederick Cancer Research and Development Center, Frederick, Maryland 21702 ANDREW W. MURRAY (33, 42), Department of Physiology, University of California at San Francisco, San Francisco, California 94143-0444 KENTARO NABESHIMA (35), Department of Biophysics, Faculty of Science, Kyoto University, Kyoto 606-01, Japan
xii
CONTRIBUTORS TO VOLUME 283
JOSEPHR. NEVINS(15), Howard Hughes Medical Institute, Department of Genetics, Duke University Medical Center, Durham, North Carolina 27710 C. NGWU (17), Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts 021292 ERICH A. NIGG (20), Department of Molecular Biology, Universityof Geneva, 1211 Geneva 4, Switzerland TAKEHARU NISHIMOTO (22), Department of Molecular Biology, Graduate School of Medical Science, Kyushu University, Fukuoka 812-82, Japan CHRIS NORBURY (4), Molecular Oncology Laboratory, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom STEPHEN A. OSMANI (39), The Weis Center for Research, Geisinger Clinic, Danville, Pennsylvania 17822 MATH-IIASPETER (27), Swiss Institute for Experimental Cancer Research, (ISREC), 1066 Epalinges, Switzerland DAWN E. PHELPS (14), Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-3280 JONATHONPINES (8), WeUcome/CRCInstitute and Department of Zoology, Cambridge CB2 1QR, United Kingdom RANDY Y. C. POON (21), Department of BiDchemistry, Hong Kong University of Science and Technology, ClearwaterBay, Kowloon, Hong Kong CAROLPRIVES(18), Department of Biological Sciences, Columbia University, New York, New York 10027 KATHERYN A. RESING (3), Department of Chemistry and Biochemistry, University of Colorado, Boulder, Colorado 80309 VOLKER R(bNICKE (23), Max-Planck-lnstitut fiir klinische und physiologische Forschung, Kerckhoff-Institut, D-61231 Bad Nauheim, Germany ALISON ROWELS (41), Imperial Cancer Research Fund, Clare Hall Laboratories, South Mimms, Herts. EN6 3LD, England
JOANV. RUDERMAN(46), Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115 PAULRUSSELL(38), Department of Molecular Biology, The Scripps Research Institute, La Jolla, California 92037 ALICIAA. RUSSO(1), Memorial Sloan-Kettering Cancer Center, Cellular Biochemistry and Biophysics Program, New York, New York 10021 SHIGEAKI SAITOH (35), Department of Biophysics, Faculty of Science, Kyoto University, Kyoto 606-01, Japan YOLANDA SANCHEZ (31), Verna and Marts McLean Department of Biochemistry, Baylot College of Medicine, Houston, Texas 77030 CORRADOSANTOCANALE(29), Imperial Cancer Research Fund, Clare Hall Laboratories, South Mimms, Hens. EN6 3LD, United Kingdom WILLIAM R. SELLERS(5), Dana-Farber Cancer Institute, Boston, Massachusetts 02115 ROBERTJ. SHEAFF(13), Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104 KAZUHIRO SHIOZAKI (38), Department of Molecular Biology, The Scripps Research Institute, La JoUa, California 92037 LILIA STEPANOVA(16), Department of Biochemistry, Baylor College of Medicine, Houston, Texas 77030 AARON F. STRAIGHT (33), Department of Physiology, University of California at San Francisco, San Francisco, California 94143-0444 P. TODDSTUKENBERG(7), Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115 VALERY SUDAKIN(46), Unit of Biochemistry, Rappaport Faculty of Medicine and Rappaport Institute for Research in Medical Sciences, Technion-IsraelInstitute of Technology, Haifa 31096, Israel E. C. SWINDELL (17), Verna and Marts McLean Department of Biochemistry, Baylot College of Medicine, Houston, Texas 77030
CONTRIBUTORS TO VOLUME 283
xiii
/~kLVARO TAVARES (47), Cancer Research
YUE XIONG (14), Department of Biochemistry
Campaign, Cell Cycle Genetics Group, Department of Anatomy and Physiology, Medical Sciences Institute, University of Dundee, Dundee DD1 4HN, Scotland PIA THt3MMES (41), Imperial Cancer Research Fund, Clare Hall Laboratories, South Mimms, Hefts. EN6 3LD, England NICOLE VALTZ (27), Programs in Genetics and Cell Biology, Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, California 94143-0448 GEORGE F. VANDE WOUDE (44), ABL-Basic Research Program, NCI-Frederick Cancer Research and Development Center, Frederick, Maryland 21702 RATI VERMA (28), California Institute of Technology, Pasadena, California 91125 TED WEINERT (33), Department of Molecular and Cellular Biology, University of Arizona, Tucson, Arizona 85721 HEIKE WILHELM (2), EMBL, Cell Biology Programme, D 69117Heidelberg, Germany J. WINSTON (17), Department of Biochemistry, Baylor College of Medicine, Houston, Texas 77030
and Biophysics, Program in Molecular Biology and Biotechnology, Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-3280 GANG XU (39), Department of Pathology and
Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 MITSUH1RO YANAGIDA (35), Department of
Biophysics, Faculty of Science, Kyoto University, Kyoto 606-01, Japan XIAN~ S. YE (39), The Weis Center for Re-
search, Geisinger Clinic, Danville, Pennsylvania 17822 JUNYING YUAN (7), Department of Cell Biol-
ogy, Harvard Medical School, Boston, Massachusetts 02115 ZHENG ZHOC (31), Department of Biology,
Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 LEONARD I. ZON (7), Howard Hughes Medi-
cal Institute and Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115